Coronis is a leading Israeli Investment Company specializing in the Biotechnology sector and focusing on highly select opportunities in the therapeutic, diagnostic and agro-bio space. Coronis' team, comprised of industry experts with complementary expertise from operational, finance, and management backgrounds, has invested since 2004 over $10M in seven high quality portfolio companies. As of August 2009, Coronis' portfolio valuation has doubled , representing an IRR of more than 30% per year. |